Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BioVacSafe-Boostrix booster vaccination study in healthy adults
2015-002879-14Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Jul 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of acellular pertussis vaccine in diphtheria, Tetanus and pertussis (2 arms), sponsored by Ghent University Hospital. Primary endpoint: Frequency of local and systemic vaccine-related clinical events. Started Jul 2015; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on 2015-002879-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002879-14.